AMP Increases Position in SGYP

Today, ahead of SGYP's January 24th PDUFA date for Trulance (IBS-C), AMP increased its position in Synergy Pharmaceuticals (SGYP) by $20K. This brings AMPs position to over $100K in SGYP.

*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon